180 related articles for article (PubMed ID: 12767523)
1. In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia.
Colovic M; Sefer D; Bogdanovic A; Suvajdzic N; Jankovic G; Atkinson HD; Milenkovic P
Cancer Lett; 2003 Jun; 195(2):153-9. PubMed ID: 12767523
[TBL] [Abstract][Full Text] [Related]
2. Biochemically targeted therapy of refractory leukemia and myeloid blast crisis of chronic granulocytic leukemia with Tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot G; Weber G
Anticancer Res; 1996; 16(6A):3341-7. PubMed ID: 9042309
[TBL] [Abstract][Full Text] [Related]
3. Plasma and cellular pharmacokinetics of m-AMSA related to in vitro toxicity towards normal and leukemic clonogenic bone marrow cells (CFU-GM, CFU-L).
Linssen P; Brons P; Knops G; Wessels H; de Witte T
Eur J Haematol; 1993 Mar; 50(3):149-54. PubMed ID: 8472810
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
5. The influence of recombinant human tumor necrosis factor alpha and its muteins used alone or in combination with 2-chlorodeoxyadenosine on normal and leukemic hematopoiesis in vitro.
Korycka A; Robak T
Leuk Res; 1997 Sep; 21(9):857-65. PubMed ID: 9393601
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia.
Nara N; Kurokawa H; Tanikawa S; Tomiyama J; Nagata K
Cancer; 1994 Jan; 73(1):92-7. PubMed ID: 8275443
[TBL] [Abstract][Full Text] [Related]
7. Combined effect of interferon-gamma and tumor necrosis factor-alpha causing suppression of leukemic blast progenitors in acute myeloblastic leukemia.
Nara N
Leuk Lymphoma; 1993 Jun; 10(3):201-7. PubMed ID: 7693101
[TBL] [Abstract][Full Text] [Related]
8. Human recombinant interferon-inducible protein-10 inhibits the proliferation of normal and acute myelogenous leukemia progenitors.
Sarris AH; Talpaz M; Deisseroth AB; Estrov Z
Leukemia; 1996 May; 10(5):757-65. PubMed ID: 8656668
[TBL] [Abstract][Full Text] [Related]
9. In vitro culture studies of blood and marrow cells in chronic myeloid leukemia at different phases of the disease.
Shih LY; Chiu WF; Dunn P; Liaw SJ
Blut; 1988 Sep; 57(3):125-30. PubMed ID: 3166388
[TBL] [Abstract][Full Text] [Related]
10. The influence of farnesyl protein transferase inhibitor R115777 (Zarnestra) alone and in combination with purine nucleoside analogs on acute myeloid leukemia progenitors in vitro.
Korycka A; Smolewski P; Robak T
Eur J Haematol; 2004 Dec; 73(6):418-26. PubMed ID: 15522064
[TBL] [Abstract][Full Text] [Related]
11. Malignant progenitors from patients with CD87+ acute myelogenous leukemia are sensitive to a diphtheria toxin-urokinase fusion protein.
Frankel AE; Beran M; Hogge DE; Powell BL; Thorburn A; Chen YQ; Vallera DA
Exp Hematol; 2002 Nov; 30(11):1316-23. PubMed ID: 12423685
[TBL] [Abstract][Full Text] [Related]
12. Colony growth in cultures from bone marrow and peripheral blood after curative treatment for leukemia and severe aplastic anemia.
Betticher DC; Huxol H; Müller R; Speck B; Nissen C
Exp Hematol; 1993 Nov; 21(12):1517-21. PubMed ID: 8405233
[TBL] [Abstract][Full Text] [Related]
13. The comparison of 2-chlorodeoxyadenosine (2-Cd A) in combination with interferon alpha (IFN alpha) or interferon gamma (IFN gamma) on granulocyte-macrophage progenitor cells (CFU-GM) and clonogenic blasts in (CFU-L) in vitro cultures.
Robak T; Korycka A
Leuk Lymphoma; 1996 Mar; 21(1-2):161-8. PubMed ID: 8907284
[TBL] [Abstract][Full Text] [Related]
14. Sensitivities of AML blast stem cells to idarubicin and daunorubicin: a comparison with normal hematopoietic progenitors.
Curtis JE; Minden MD; Minkin S; McCulloch EA
Leukemia; 1995 Mar; 9(3):396-404. PubMed ID: 7533865
[TBL] [Abstract][Full Text] [Related]
15. Biochemically directed therapy of leukemia with tiazofurin, a selective blocker of inosine 5'-phosphate dehydrogenase activity.
Tricot GJ; Jayaram HN; Lapis E; Natsumeda Y; Nichols CR; Kneebone P; Heerema N; Weber G; Hoffman R
Cancer Res; 1989 Jul; 49(13):3696-701. PubMed ID: 2567208
[TBL] [Abstract][Full Text] [Related]
16. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant GM-CSF and recombinant G-CSF on colony formation of blast progenitors in acute myeloblastic leukemia.
Motoji T; Takanashi M; Fuchinoue M; Masuda M; Oshimi K; Mizoguchi H
Exp Hematol; 1989 Jan; 17(1):56-60. PubMed ID: 2783249
[TBL] [Abstract][Full Text] [Related]
18. Effect of stem cell factor on leukemic progenitor cell growth and sensitivity to cytosine-arabinoside.
Viallard JF; Grosset C; Lacombe F; David S; Mahon FX; Barbot C; Vianes I; Dupouy M; Reiffers J
Leuk Res; 1996; 20(11-12):915-23. PubMed ID: 9009249
[TBL] [Abstract][Full Text] [Related]
19. Effects of H-7 and staurosporine on proliferation and self-renewal of acute myeloid leukemia progenitors.
Laredo J; Demur C; Muller C; Saivin S; Cassar G; Bousquet C; Dastugue N; Jaffrézou JP; Colombies P; Laurent G
Leukemia; 1993 Jun; 7(6):813-20. PubMed ID: 8501977
[TBL] [Abstract][Full Text] [Related]
20. Interaction of 2-chlorodeoxyadenosine in combination either with interferons or recombinant human tumor necrosis factor alpha on myeloid progenitor cells in vitro.
Korycka A; Robak T
Arch Immunol Ther Exp (Warsz); 1996; 44(4):259-64. PubMed ID: 9017167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
